The inhibition of monoacylglycerol lipase by URB602 showed an anti‐inflammatory and anti‐nociceptive effect in a murine model of acute inflammation

Ethical guidelines for investigations of experimental pain in conscious animals.

Zimmermann, M. (1983) · Pain · doi:10.1016/0304-3959(83)90201-4 · Cited by 7,762

Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor

Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633

A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia

Hargreaves, K., Dubner, R. A., Brown, F. J., Flores, C., & Joris, J. L. (1988) · Pain · doi:10.1016/0304-3959(88)90026-7 · Cited by 5,155

Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors

Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., et al. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00109-d · Cited by 2,913

2-Arachidonoylgylcerol: A Possible Endogenous Cannabinoid Receptor Ligand in Brain

Sugiura, T., Kondo, S., Sukagawa, A., Nakane, S., Shinoda, A., Itoh, K., Yamashita, A., & Waku, K. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2437 · Cited by 2,196

A second endogenous cannabinoid that modulates long-term potentiation

Stella, N., Schweitzer, P., & Piomelli, D. (1997) · Nature · doi:10.1038/42015 · Cited by 1,496

An endocannabinoid mechanism for stress-induced analgesia

Hohmann, A. G., Suplita, R. L., Bolton, N. M., Neely, M. H., Fegley, D., Mangieri, R., Krey, J. F., Michael Walker, J., Holmes, P. V., Crystal, J. D., et al. (2005) · Nature · doi:10.1038/nature03658 · Cited by 778

SR 144528, the First Potent and Selective Antagonist of the CB2 Cannabinoid Receptor

Rinaldi, M. L., Barth, F., Millan, J., Derocq, J., Casellas, P., Congy, C., Oustric, D., Sarran, M., Bouaboula, M., Calandra, B., et al. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37266-0 · Cited by 716

Cannabinoid structure-activity relationships: correlation of receptor binding and in vivo activities.

Compton, D. M., Rice, K. C., Costa, B., Razdan, R. K., Melvin, L. S., Johnson, M. R., & Martin, B. R. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38122-x · Cited by 459

Endocannabinoid 2-Arachidonyl Glycerol Is a Full Agonist through Human Type 2 Cannabinoid Receptor: Antagonism by Anandamide

Gonsiorek, W., Lunn, C. A., Fan, X., Narula, S. K., Lundell, D. J., & Hipkin, R. W. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)26516-0 · Cited by 376

Effects of cannabinoids and cannabinoid‐enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes

De Petrocellis, L., Ligresti, A., Moriello, A. S., Allarà, M., Bisogno, T., Petrosino, S., Stott, C. G., & Di Marzo, V. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01166.x · Cited by 946

Targeting the endocannabinoid system: to enhance or reduce?

Marzo, V. D. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2553 · Cited by 822

The CB2 receptor and its role as a regulator of inflammation

Turcotte, C., Blanchet, M., Laviolette, M., & Flamand, N. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2300-4 · Cited by 632

Endocannabinoid signaling as a synaptic circuit breaker in neurological disease

Katona, I., & Freund, T. F. (2008) · Nature Medicine · doi:10.1038/nm.f.1869 · Cited by 579

The Endocannabinoid System and Pain

Guindon, J., & Hohmann, A. (2009) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152709789824660 · Cited by 476

Chemical Probes of Endocannabinoid Metabolism

Blankman, J. L., & Cravatt, B. F. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.006387 · Cited by 327

The endogenous cannabinoid system: a budding source of targets for treating inflammatory and neuropathic pain

Donvito, G., Nass, S. R., Wilkerson, J. L., Curry, Z. A., Schurman, L. D., Kinsey, S. G., & Lichtman, A. H. (2018) · Neuropsychopharmacology · doi:10.1038/npp.2017.204 · Cited by 301

Regulation of inflammation by cannabinoids, the endocannabinoids 2-arachidonoyl-glycerol and arachidonoyl-ethanolamide, and their metabolites

Turcotte, C., Chouinard, F., Lefebvre, J. S., & Flamand, N. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.3ru0115-021r · Cited by 258

2-Arachidonoylglycerol: A signaling lipid with manifold actions in the brain

Baggelaar, M. P., Maccarrone, M., & van der Stelt, M. (2018) · Progress in Lipid Research · doi:10.1016/j.plipres.2018.05.002 · Cited by 224

Synthesis and in Vitro Evaluation of N-Substituted Maleimide Derivatives as Selective Monoglyceride Lipase Inhibitors

Matuszak, N., Muccioli, G. G., Labar, G., & Lambert, D. M. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900461w · Cited by 147

Inhibition of COX‐2 expression by endocannabinoid 2‐arachidonoylglycerol is mediated via PPAR‐γ

Du, H., Chen, X., Zhang, J., & Chen, C. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01444.x · Cited by 136

The monoacylglycerol lipase inhibitor JZL184 suppresses inflammatory pain in the mouse carrageenan model

Ghosh, S., Wise, L. E., Chen, Y., Gujjar, R., Mahadevan, A., Cravatt, B. F., & Lichtman, A. H. (2013) · Life Sciences · doi:10.1016/j.lfs.2012.06.020 · Cited by 127

Endocannabinoid 2-arachidonoylglycerol protects neurons against β-amyloid insults

Chen, X., Zhang, J., & Chen, C. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.01.024 · Cited by 123

Neuroprotection in Oxidative Stress-Related Neurodegenerative Diseases: Role of Endocannabinoid System Modulation

Pálóczi, J., Varga, Z. V., Hasko, G., & Pacher, P. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7144 · Cited by 129

Peripheral antinociceptive effects of inhibitors of monoacylglycerol lipase in a rat model of inflammatory pain

Guindon, J., Guijarro, A. I., Piomelli, D., & Hohmann, A. G. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01192.x · Cited by 120

Current evidence of cannabinoid‐based analgesia obtained in preclinical and human experimental settings

Lötsch, J., Weyer-Menkhoff, I., & Tegeder, I. (2017) · European Journal of Pain · doi:10.1002/ejp.1148 · Cited by 123

Discovery of Potent and Reversible Monoacylglycerol Lipase Inhibitors

King, A. R., Dotsey, E. Y., Lodola, A., Jung, K., Ghomian, A., Qiu, Y., Fu, J., Mor, M., & Piomelli, D. (2009) · Chemistry & Biology · doi:10.1016/j.chembiol.2009.09.012 · Cited by 117

A Review on the Monoacylglycerol Lipase: At the Interface Between Fat and Endocannabinoid Signalling

Labar, G., Wouters, J., & Lambert, D. M. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710791859414 · Cited by 111

URB602 Inhibits Monoacylglycerol Lipase and Selectively Blocks 2-Arachidonoylglycerol Degradation in Intact Brain Slices

King, A. R., Duranti, A., Tontini, A., Rivara, S., Rosengarth, A., Clapper, J. R., Astarita, G., Geaga, J. A., Luecke, H., Mor, M., et al. (2007) · Chemistry & Biology · doi:10.1016/j.chembiol.2007.10.017 · Cited by 108

Enhanced endocannabinoid tone as a potential target of pharmacotherapy

Toczek, M., & Malinowska, B. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.04.054 · Cited by 108

Elevating endocannabinoid levels: pharmacological strategies and potential therapeutic applications

Pertwee, R. G. (2013) · Proceedings of The Nutrition Society · doi:10.1017/s0029665113003649 · Cited by 100

Dynamic Regulation of the Endocannabinoid System: Implications for Analgesia

Sagar, D. R., Gaw, A. G., Okine, B. N., Woodhams, S. G., Wong, A., Kendall, D. A., & Chapman, V. (2009) · Molecular Pain · doi:10.1186/1744-8069-5-59 · Cited by 99

A critical cysteine residue in monoacylglycerol lipase is targeted by a new class of isothiazolinone‐based enzyme inhibitors

King, A., Lodola, A., Carmi, C., Fu, J., Mor, M., & Piomelli, D. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00276.x · Cited by 91

2‐Arachidonoylglycerol elicits neuroprotective effects on excitotoxically lesioned dentate gyrus granule cells via abnormal‐cannabidiol‐sensitive receptors on microglial cells

Kreutz, S., Koch, M., Böttger, C., Ghadban, C., Korf, H., & Dehghani, F. (2008) · Glia · doi:10.1002/glia.20756 · Cited by 87

From endocannabinoid profiling to ‘endocannabinoid therapeutics’

Ligresti, A., Petrosino, S., & Marzo, V. D. (2009) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2009.04.615 · Cited by 88

The monoacylglycerol lipase inhibitor JZL 184 attenuates LPS ‐induced increases in cytokine expression in the rat frontal cortex and plasma: differential mechanisms of action

Kerr, D., Harhen, B., Okine, B. N., Egan, L. J., Finn, D. P., & Roche, M. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02237.x · Cited by 77

Development of a potent inhibitor of 2-arachidonoylglycerol hydrolysis with antinociceptive activity in vivo

Bisogno, T., Ortar, G., Petrosino, S., Morera, E., Palazzo, E., Nalli, M., Maione, S., & Marzo, V. D. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2008.10.007 · Cited by 76

Increasing levels of the endocannabinoid 2-AG is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease

Mounsey, R. B., Mustafa, S., Robinson, L., Ross, R. A., Riedel, G., Pertwee, R. G., & Teismann, P. (2015) · Experimental Neurology · doi:10.1016/j.expneurol.2015.07.024 · Cited by 75

Distribution and function of monoacylglycerol lipase in the gastrointestinal tract

Duncan, M., Thomas, A. D., Cluny, N. L., Patel, A., Patel, K. D., Lutz, B., Piomelli, D., Alexander, S. P. H., & Sharkey, K. A. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.90500.2008 · Cited by 71

Actions of the dual FAAH/MAGL inhibitor JZL195 in a murine neuropathic pain model

Barnes, N. S. A., Mitchell, V. A., Kazantzis, N. P., & Vaughan, C. W. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13337 · Cited by 72

Pharmacological inhibition of MAGL attenuates experimental colon carcinogenesis

Pagano, E., Borrelli, F., Orlando, P., Romano, B., Monti, M., Morbidelli, L., Aviello, G., Imperatore, R., Capasso, R., Piscitelli, F., et al. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.02.002 · Cited by 68

Actions of the dual FAAH/MAGL inhibitor JZL195 in a murine inflammatory pain model

Anderson, W. B., Gould, M. J., Torres, R. D., Mitchell, V. A., & Vaughan, C. W. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.12.018 · Cited by 67

The Impact of the CB2 Cannabinoid Receptor in Inflammatory Diseases: An Update

Rakotoarivelo, V., Mayer, T. Z., Simard, M., Flamand, N., & Marzo, V. D. (2024) · Molecules · doi:10.3390/molecules29143381 · Cited by 72

Monoglyceride lipase: Structure and inhibitors

Scalvini, L., Piomelli, D., & Mor, M. (2015) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2015.07.011 · Cited by 69

Controlling 2-arachidonoylglycerol metabolism as an anti-inflammatory strategy

Alhouayek, M., Masquelier, J., & Muccioli, G. G. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.07.009 · Cited by 71

Characterization of the Effects of Reuptake and Hydrolysis Inhibition on Interstitial Endocannabinoid Levels in the Brain: An in Vivo Microdialysis Study

Wiskerke, J., Irimia, C., Cravatt, B. F., Vries, T. J. D., Schoffelmeer, A. N. M., Pattij, T., & Parsons, L. H. (2012) · ACS Chemical Neuroscience · doi:10.1021/cn300036b · Cited by 68

The dual fatty acid amide hydrolase/TRPV1 blocker, N-arachidonoyl-serotonin, relieves carrageenan-induced inflammation and hyperalgesia in mice

Costa, B., Bettoni, I., Petrosino, S., Comelli, F., Giagnoni, G., & Di Marzo, V. (2010) · Pharmacological Research · doi:10.1016/j.phrs.2010.02.001 · Cited by 64

Discovery of 1,5-Diphenylpyrazole-3-Carboxamide Derivatives as Potent, Reversible, and Selective Monoacylglycerol Lipase (MAGL) Inhibitors

Tabrizi, M. A., Baraldi, P. G., Baraldi, S., Ruggiero, E., Stefano, L. D., Rizzolio, F., Mannelli, L. D. C., Ghelardini, C., Chicca, A., Lapillo, M., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01845 · Cited by 62

Pharmacological inhibition of endocannabinoid degradation modulates the expression of inflammatory mediators in the hypothalamus following an immunological stressor

Kerr, D. M., Burke, N. N., Ford, G. K., Connor, T., Harhen, B., Egan, L. J., Finn, D. P., & Roche, M. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.09.032 · Cited by 58

Cannabinoid receptor 2 deficiency exacerbates inflammation and neutrophil recruitment

Kapellos, T. S., Taylor, L., Feuerborn, A., Valaris, S., Hussain, M. T., Rainger, G. E., Greaves, D. R., & Iqbal, A. J. (2019) · The FASEB Journal · doi:10.1096/fj.201802524r · Cited by 54

JZL184 is anti-hyperalgesic in a murine model of cisplatin-induced peripheral neuropathy

Khasabova, I. A., Yao, X., Paz, J., Lewandowski, C. T., Lindberg, A. E., Coicou, L., Burlakova, N., Simone, D. A., & Seybold, V. S. (2014) · Pharmacological Research · doi:10.1016/j.phrs.2014.09.008 · Cited by 50

Inhibitors of the Endocannabinoid-Degrading Enzymes, or how to Increase Endocannabinoids Activity by Preventing their Hydrolysis

Feledziak, M., Lambert, D. M., Marchand‐Brynaert, J., & Muccioli, G. G. (2011) · Recent Patents on CNS Drug Discovery · doi:10.2174/157488912798842223 · Cited by 50

Sex differences in the expression of the endocannabinoid system within V1M cortex and PAG of Sprague Dawley rats

Levine, A. A., Liktor‐Busa, E., Lipinski, A. A., Couture, S. A., Balasubramanian, S., Aicher, S. A., Langlais, P. R., Vanderah, T. W., & Largent‐Milnes, T. M. (2021) · Biology of Sex Differences · doi:10.1186/s13293-021-00402-2 · Cited by 53

Discovery and Development of Endocannabinoid-Hydrolyzing Enzyme Inhibitors

Minkkilä, A., Saario, S. M., & Nevalainen, T. (2010) · Current Topics in Medicinal Chemistry · doi:10.2174/156802610791164238 · Cited by 46

The Potential of Inhibitors of Endocannabinoid Metabolism for Drug Development: A Critical Review

Fowler, C. J. (2015) · Handbook of experimental pharmacology · doi:10.1007/978-3-319-20825-1_4 · Cited by 46

Full Mass Spectrometric Characterization of Human Monoacylglycerol Lipase Generated by Large-Scale Expression and Single-Step Purification

Zvonok, N., Williams, J. S., Johnston, M., Pandarinathan, L., Janero, D. R., Li, J., Krishnan, S. C., & Makriyannis, A. (2008) · Journal of Proteome Research · doi:10.1021/pr700839z · Cited by 43

The exogenous administration of CB2 specific agonist, GW405833, inhibits inflammation by reducing cytokine production and oxidative stress

Parlar, A., Arslan, S. O., Doğan, M. F., Çam, S. A., Yal�in, A., Elibol, E., �zer, M., ��kardeş, F., & Kara, H. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.6753 · Cited by 43

Membrane phospholipid bilayer as a determinant of monoacylglycerol lipase kinetic profile and conformational repertoire

Nasr, M. L., Shi, X., Bowman, A. L., Johnson, M., Zvonok, N., Janero, D. R., Vemuri, K. V., Wales, T. E., Engen, J. R., & Makriyannis, A. (2013) · Protein Science · doi:10.1002/pro.2257 · Cited by 42

Dual Inhibition of FAAH and MAGL Counteracts Migraine-like Pain and Behavior in an Animal Model of Migraine

Greco, R., Demartini, C., Francavilla, M., Zanaboni, A. M., & Tassorelli, C. (2021) · Cells · doi:10.3390/cells10102543 · Cited by 44

Peripheral modulation of the endocannabinoid system in metabolic disease

Shrestha, N., Cuffe, J. S. M., Hutchinson, D. S., Headrick, J. P., Perkins, A. V., McAinch, A. J., & Hryciw, D. H. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.01.029 · Cited by 43

Comparative biochemical characterization of the monoacylglycerol lipase inhibitor KML29 in brain, spinal cord, liver, spleen, fat and muscle tissue

Pasquarelli, N., Porazik, C., Hanselmann, J., Weydt, P., Ferger, B., & Witting, A. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.12.001 · Cited by 38

Endocannabinoid System in the Airways

Bozkurt, T. E. (2019) · Molecules · doi:10.3390/molecules24244626 · Cited by 41

Non-psychotropic analgesic drugs from the endocannabinoid system: “Magic bullet” or “multiple-target” strategies?

Starowicz, K., & Marzo, V. D. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.01.075 · Cited by 39

Cannabis sativaand the Endogenous Cannabinoid System: Therapeutic Potential for Appetite Regulation

Farrimond, J. A., Mercier, M. S., Whalley, B. J., & Williams, C. M. (2011) · Phytotherapy Research · doi:10.1002/ptr.3375 · Cited by 37

Antinociceptive effects of tetrazole inhibitors of endocannabinoid inactivation: cannabinoid and non‐cannabinoid receptor‐mediated mechanisms

Maione, S., Morera, E., Marabese, I., Ligresti, A., Luongo, L., Ortar, G., & Marzo, V. D. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.308 · Cited by 33

Time-dependent expression and distribution of monoacylglycerol lipase during the skin-incised wound healing in mice

Ma, W.-X., Yu, T.-S., Fan, Y., Zhang, S., Ren, P., Wang, S.-B., Zhao, R., Pi, J., & Guan, D.-W. (2011) · International Journal of Legal Medicine · doi:10.1007/s00414-011-0567-4 · Cited by 31

The biology that underpins the therapeutic potential of cannabis-based medicines for the control of spasticity in multiple sclerosis

Baker, D., Pryce, G., Jackson, S. J., Bolton, C., & Giovannoni, G. (2012) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2011.11.001 · Cited by 31

CB2 Agonist (AM1241) Improving Effect on Ovalbumin-Induced Asthma in Rats.

Fathollahipour, S., Koosha, M., Tavakoli, J., Maziarfar, S., & Mehrabadi, J. F. (2020) · PubMed Central · doi:10.22037/ijpr.2019.1101002 · Cited by 29

Potentiation of microglial endocannabinoid signaling alleviates neuroinflammation in Alzheimer's disease

Rapaka, D., Bitra, V. R., Challa, S. R., & Adiukwu, P. C. (2021) · Neuropeptides · doi:10.1016/j.npep.2021.102196 · Cited by 29

Cannabinoid type 2 receptor (CB2R) distribution in dermatomyositis skin and peripheral blood mononuclear cells (PBMCs) and in vivo effects of LenabasumTM

Maddukuri, S., Patel, J., Diaz, D., Chen, K. L., Wysocka, M., Bax, C. E., Li, Y., Ravishankar, A., Grinnell, M., Zeidi, M., et al. (2022) · Arthritis Research & Therapy · doi:10.1186/s13075-021-02665-x · Cited by 26

Effects of monoacylglycerol lipase inhibitor URB602 on lung ischemia-reperfusion injury in mice

Xiong, Y., Yao, H., Cheng, Y., Gong, D., Liao, X., & Wang, R. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.10.098 · Cited by 25

The endocannabinoid system in canine Steroid-Responsive Meningitis-Arteritis and Intraspinal Spirocercosis

Freundt-Revilla, J., Heinrich, F., Zoerner, A. A., Gesell, F. K., Beyerbach, M., Shamir, M. H., Oevermann, A., Baumgärtner, W., & Tipold, A. (2018) · PLoS ONE · doi:10.1371/journal.pone.0187197 · Cited by 24

Pretreatment with the monoacylglycerol lipase inhibitor URB602 protects from the long-term consequences of neonatal hypoxic–ischemic brain injury in rats

Carloni, S., Alconada, D. A., Girelli, S., Duranti, A., Tontini, A., Piomelli, D., Hilario, E., Alvarez, A. A., & Balduini, W. (2012) · Pediatric Research · doi:10.1038/pr.2012.91 · Cited by 22

Inhibition of Endocannabinoid-Metabolizing Enzymes in Peripheral Tissues Following Developmental Chlorpyrifos Exposure in Rats

Buntyn, R. W., Alugubelly, N., Hybart, R., Mohammed, A. N., Nail, C. A., Parker, G. C., Ross, M. K., & Carr, R. L. (2017) · International Journal of Toxicology · doi:10.1177/1091581817725272 · Cited by 21

Design, synthesis, molecular modelling and in vitro cytotoxicity analysis of novel carbamate derivatives as inhibitors of Monoacylglycerol lipase

Lauria, S., Perrotta, C., Casati, S., Renzo, I. D., Ottria, R., Eberini, I., Palazzolo, L., Parravicini, C., & Ciuffreda, P. (2018) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2018.04.024 · Cited by 20

Active-Site Inhibitors Modulate the Dynamic Properties of Human Monoacylglycerol Lipase: A Hydrogen Exchange Mass Spectrometry Study

Karageorgos, I. L., Wales, T. E., Janero, D. R., Zvonok, N., Vemuri, K. V., Engen, J. R., & Makriyannis, A. (2013) · Biochemistry · doi:10.1021/bi400430k · Cited by 19

Inhibition of DAGLβ as a therapeutic target for pain in sickle cell disease

Khasabova, I. A., Gable, J., Johns, M. E., Khasabov, S. G., Kalyuzhny, A. E., Golovko, M. Y., Golovko, S. A., Kiven, S. B., Gupta, K., Seybold, V. S., et al. (2022) · Haematologica · doi:10.3324/haematol.2021.280460 · Cited by 17

Phenolics, antioxidant and anti-inflammatory activities of Melia azedarach extracts

Aoudia, H., Oomah, B. D., Zaidi, F., Yahiaoui-Zaidi, R., Drover, J. C. G., & Harrison, J. E. (2013) · International journal of applied research in natural products · Cited by 16

Highly Predictive Ligand‐based Pharmacophore and Homology Models of ABHD6

Bowman, A. L., & Makriyannis, A. (2012) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12086 · Cited by 13

Refined homology model of monoacylglycerol lipase: toward a selective inhibitor

Bowman, A. L., & Makriyannis, A. (2009) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-009-9289-9 · Cited by 11

Therapeutic Targeting of Peripheral Cannabinoid Receptors in Inflammatory and Neuropathic Pain States

Spigelman, I. (2009) · Frontiers in neuroscience · doi:10.1201/9781439812105-c5 · Cited by 12

On the Biomedical Properties of Endocannabinoid Degradation and Reuptake Inhibitors: Pre-clinical and Clinical Evidence

Paredes-Ruiz, K. J., Chavira-Ramos, K., Orozco‐Morales, M., Karasu, Ç., Tinkov, A. A., Aschner, M., Santamarı́a, A., & Colín-González, A. L. (2021) · Neurotoxicity Research · doi:10.1007/s12640-021-00424-z · Cited by 10

A Review on Structurally Diversified Synthesized Molecules as Monoacylglycerol Lipase Inhibitors and their Therapeutic uses

Kashyap, A., Kumar, S., & Dutt, R. (2022) · Current Drug Research Reviews · doi:10.2174/2589977514666220301111457 · Cited by 11

Substrate selectivity of bacterial monoacylglycerol lipase based on crystal structure

Tsurumura, T., & Tsuge, H. (2014) · Journal of Structural and Functional Genomics · doi:10.1007/s10969-014-9181-2 · Cited by 10

Sapropterin (BH4) Aggravates Autoimmune Encephalomyelitis in Mice

Schmitz, K., Trautmann, S., Hahnefeld, L., Fischer, C., Schreiber, Y., Wilken‐Schmitz, A., Gurke, R., Brunkhorst, R., Werner, E. R., Watschinger, K., et al. (2021) · Neurotherapeutics · doi:10.1007/s13311-021-01043-4 · Cited by 9

Acute Effects of Monoacylglycerol Lipase Inhibitor ABX1431 on Neuronal Hyperexcitability, Nociception, Locomotion, and the Endocannabinoid System in HIV-1 Tat Male Mice

Yadav-Samudrala, B. J., Ravula, H., Barmada, K. M., Dodson, H., Poklis, J. L., Ignatowska-Jankowska, B. M., Lichtman, A. H., Reissner, K. J., & Fitting, S. (2024) · Cannabis and Cannabinoid Research · doi:10.1089/can.2023.0247 · Cited by 8

2-Arylpropionic Acid Pyrazolamides as Cannabinoid CB2 Receptor Inverse Agonists Endowed with Anti-Inflammatory Properties

de Oliveira, D. R., Maia, R. D. C., França, P. R. D. C., Fernandes, P. D., Barbosa, G., Lima, L. M., & Fraga, C. A. M. (2022) · Pharmaceuticals · doi:10.3390/ph15121519 · Cited by 5

The function of the endocannabinoid system

Cascio, M. G., & Pertwee, R. G. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511706080.004 · Cited by 3

SGIP1 Deletion in Mice Attenuates Mechanical Hypersensitivity Elicited by Inflammation

Durydivka, O., Kuchař, M., & Blahoš, J. (2024) · Cannabis and Cannabinoid Research · doi:10.1089/can.2024.0020 · Cited by 2

Endocannabinoids and related compounds as modulators of angiogenesis: Concepts and clinical significance

Afshar, S., Abbasinazari, M., Amin, G., Farrokhian, A., Sistanizad, M., Afshar, F., & Khalili, S. (2022) · Cell Biochemistry and Function · doi:10.1002/cbf.3754 · Cited by 2

Immunomodulatory effect of Cannabis root extract on inflammatory cascades via endocannabinoid system regulation

Jin, H.-L., Yu, G., Jung, H., Lee, M.-S., Kim, H., Lim, D., & Park, W. (2026) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-026-05317-2 · Cited by 1

Fatty Pain Cures

Imming, P. (2007) · Chemistry & Biology · doi:10.1016/j.chembiol.2007.12.003 · Cited by 1

Targeting the Endocannabinoid Metabolic Enzymes to Reduce Inflammatory Pain

Ghosh, S. (2014) · VCU Scholars Compass (Virginia Commonwealth University) · doi:10.25772/ngv2-th75 · Cited by 1

Study of the interaction between 3,4 methylenedioximethamphetamine and the endocannabinoid system

Touriño, C. (2009) · Repositori digital de la UPF (Universitat Pompeu Fabra)

Bioactive Lipids in Nociception

Ermund, A. (2008) · Lund University Publications (Lund University)

Functional Autoradiography as a Pharmacological Approach for Studying G Protein-Coupled Lipid Receptor Signalling

Aaltonen, N. (2013) · UEF eRepo (University of Eastern Finland)

Philosophy at Virginia Commonwealth University.

Booker, L. (2011)

Analysis of the structure and function of endocannabinoid-hydrolyzing enzymes using biophysical and nanomedical techniques

Johnson, M. J. (2014) · doi:10.17760/d20197124

Biochemical and biophysical characterization of human monoacylglycerol lipase in solution and in the presence of nanodisc membrane models

Nasr, M. L. (2012) · doi:10.17760/d20238396

Design, synthesis, methodology development, and evaluation of PET imaging agents targeting cancer and CNS disorders

Yuan, G. (2017) · doi:10.17760/d20251581

New target proteins for drug discovery in colon cancer

Pagano, E. (2018)

Differential roles of the two major endocannabinoid hydrolyzing enzymes in cannabinoid receptor tolerance and somatic withdrawal

Schlosburg, J. E. (2010) · VCU Scholars Compass (Virginia Commonwealth University) · doi:10.25772/tss0-g006

The mechanism of monoacylglycerol lipase (MGL) inactivation

Karageorgos, I. L. (2012) · doi:10.17760/d20002973

Therapeutic implications of the endocannabinoid system in neurodegenerative diseases

Goren, A., & University of Rome "G.Marconi" (2015) · Clinical Case Reports and Reviews · doi:10.15761/ccrr.1000126

URB602

Alexander, S. P. H. (2008) · xPharm: The Comprehensive Pharmacology Reference · doi:10.1016/b978-008055232-3.64104-2

Advances in Small Molecule Research Targeting Monoacylglycerol Lipase in Drug Discovery

Chen, S., Yang, J., Hu, W., Jh, G., Chen, L., Zhang, J., Zhang, B., & Mao, W. (2026) · Medicinal Research Reviews · doi:10.1002/med.70089

BindingDB Entry 50030705: Synthesis and in vitro evaluation of N-substituted maleimide derivatives as selective monoglyceride lipase inhibitors.

BindingDB (2010) · UC San Diego · doi:10.7270/q2tm7b59

BindingDB Entry 4628: Discovery of potent and reversible monoacylglycerol lipase inhibitors.

BindingDB (2011) · UC San Diego · doi:10.7270/q2hh6hj3

BindingDB Entry 50000616: Discovery of 1,5-Diphenylpyrazole-3-Carboxamide Derivatives as Potent, Reversible, and Selective Monoacylglycerol Lipase (MAGL) Inhibitors.

BindingDB (2019) · UC San Diego · doi:10.7270/q2jm2d3v

BindingDB Entry 4617: URB602 inhibits monoacylglycerol lipase and selectively blocks 2-arachidonoylglycerol degradation in intact brain slices.

BindingDB (2011) · UC San Diego · doi:10.7270/q2xs5sw0

Inhibitors of monoacylglycerol lipase as novel analgesics

Hohmann, A. G. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707153 · Cited by 24

The antinociceptive effects of intraplantar injections of 2‐arachidonoyl glycerol are mediated by cannabinoid CB2receptors

Guindon, J., Desroches, J., & Beaulieu, P. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706990 · Cited by 102

Peripheral antinociceptive effects of inhibitors of monoacylglycerol lipase in a rat model of inflammatory pain

Guindon, J., Guijarro, A. I., Piomelli, D., & Hohmann, A. G. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01192.x · Cited by 120

Behavioral and Anti-inflammatory Effects of MAGL Inhibition in a Mouse Model of Inflammatory Arthritis

Steele, F. F. (2019) · doi:10.33915/etd.4114

Pharmacologic Characterization of JNJ-42226314, [1-(4-Fluorophenyl)indol-5-yl]-[3-[4-(thiazole-2-carbonyl)piperazin-1-yl]azetidin-1-yl]methanone, a Reversible, Selective, and Potent Monoacylglycerol Lipase Inhibitor

Wyatt, R. M., Fraser, I. C., Welty, N., Lord, B., Wennerholm, M. L., Sutton, S. W., Ameriks, M. K., Dugovic, C., Yun, S., White, A., et al. (2019) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.119.262139 · Cited by 30